您的位置：首页 > 产品中心 > 162412-70-6， PD-156707
PD-156707
产品别名
162412-70-6
PD-156707
α-[2-(4-Methoxyphenyl)-2-oxo-1-[(3,4,5-trimethoxyphenyl)methyl]ethylidene]-1,3-benzodioxole-5-acetic acid sodium salt
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C28H25O9·Na |
| Molecular weight | 528.48 |
| PubChem Substance ID【PubChem化学物质编号】 | 329823726 |
| NACRES | NA.77 |
| Biochem/physiol Actions【生化/生理作用】 | PD-156707 is a selective endothelin receptor (ETA) antagonist. |
| Features and Benefits【特点和优势】 | This compound is featured on the Endothelin Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. |
| Other Notes【其他说明】 | This compound was developed by Pfizer for Neuroscience research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
| Legal Information【法律信息】 | Sold for research purposes under agreement from Pfizer Inc. Pfizer is a registered trademark of Pfizer, Inc. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| manufacturer/tradename | Pfizer® |
| color【颜色】 | white to off-white |
| solubility【溶解性】 | DMSO: ≥20 mg/mL |
| originator【创始人】 | Pfizer |
| storage temp.【储存温度】 | room temp |
| SMILES string | COc1ccc(cc1)C(=O)\C(Cc2cc(OC)c(OC)c(OC)c2)=C(/C(=O)O[Na])c3ccc4OCOc4c3 |
| InChI | 1S/C28H26O9.Na/c1-32-19-8-5-17(6-9-19)26(29)20(11-16-12-23(33-2)27(35-4)24(13-16)34-3)25(28(30)31)18-7-10-21-22(14-18)37-15-36-21;/h5-10,12-14H,11,15H2,1-4H3,(H,30,31);/q;+1/p-1/b25-20-; |
| InChI key | ZLHQEGFYBMZQGM-RKVLWQGQSA-M |
| packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS09 |
| Signal word【警示用语：】 | Warning |
| Hazard Statements | H410 |
| Precautionary Statements | P273 - P501 |
| Hazard Classifications【危险分类】 | Aquatic Acute 1 - Aquatic Chronic 1 |
| Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
| WGK | WGK 3 |
